Characterization of murine TWEAK and its receptor (Fn14) by monoclonal antibodies
about
Reduced sTWEAK and increased sCD163 levels in HIV-infected patients: modulation by antiretroviral treatment, HIV replication and HCV co-infection.The TWEAK-Fn14 system is a critical regulator of denervation-induced skeletal muscle atrophy in mice.Full-length, membrane-anchored TWEAK can function as a juxtacrine signaling molecule and activate the NF-kappaB pathwayThe interplay between surfaces and soluble factors define the immunologic and angiogenic properties of myeloid dendritic cells.TWEAK affects keratinocyte G2/M growth arrest and induces apoptosis through the translocation of the AIF protein to the nucleus.Inflammatory cytokines and survival factors from serum modulate tweak-induced apoptosis in PC-3 prostate cancer cells.Development of an Fn14 agonistic antibody as an anti-tumor agent.Adhesion to substrates induces dendritic cell endothelization and decreases immunological response.Anti-TWEAK monoclonal antibodies reduce vascular damage and leucocyte infiltration in a mouse model of cutaneous reverse passive Arthus reaction.Therapeutic potential of the TWEAK/Fn14 pathway in intractable gastrointestinal cancer.Induction of tumor-specific T cell immunity by anti-DR5 antibody therapy.Development and characterization of a potent immunoconjugate targeting the Fn14 receptor on solid tumor cells.The cytokine TWEAK modulates renal tubulointerstitial inflammation.The TWEAK-Fn14 cytokine-receptor axis: discovery, biology and therapeutic targetingTWEAK-Fn14 Cytokine-Receptor Axis: A New Player of Myocardial Remodeling and Cardiac FailureThe role of tumor necrosis factor-like weak inducer of apoptosis in atherosclerosis via its two different receptors.Myxoma Virus Induces Ligand Independent Extrinsic Apoptosis in Human Myeloma CellsTweak induces mammary epithelial branching morphogenesis.Involvement of GSK-3beta in TWEAK-mediated NF-kappaB activation.Role of Omentin, Vaspin, Cardiotrophin-1, TWEAK and NOV/CCN3 in Obesity and Diabetes DevelopmentTWEAK/Fn14 Axis-Targeted Therapeutics: Moving Basic Science Discoveries to the Clinic.Soluble TNF-like weak inducer of apoptosis (TWEAK) enhances poly(I:C)-induced RIPK1-mediated necroptosis
P2860
Q31152445-BC4E2EAF-CBAF-4C1A-BACD-EFFCE83C4393Q33751732-16528BFD-4C8A-4C76-A22E-E81570270370Q33885108-5E20BB12-3FBA-4582-848B-7DF6E15FC6CDQ33924531-76B16265-BA23-4886-813B-BAC057539ABEQ34206359-2EDD1115-CF5E-4A58-B4D9-C5AF4E841238Q34450860-ED54C566-410E-48CA-8FB3-B71A4DCDDBCBQ35556794-B5A06A8B-29A6-4513-AF37-FA7D72B02754Q36146867-D04D260C-9EB1-43CF-BF09-B1499614A60CQ36165761-210EB0A4-7A1C-4A92-B042-EDBF80DC1CEEQ36230448-19DAD546-038D-4664-BEA5-720018E3B214Q36399234-21C4AC57-764A-4F9B-8CBF-FC4C80174796Q36469716-D6AA6C21-BE3D-452F-A0AE-57E75F6FD707Q36666882-DF793CAF-8561-4967-BF93-5E6257434E38Q37135363-E70AC856-DA14-422D-A256-FC01C6E09A0AQ38194552-47E37E78-2DB9-41F0-9F58-FBA87C0C9793Q38638020-BF7CAA23-D953-4B73-9757-DE311608AFC9Q39633869-30B52E39-17F1-49B8-9229-3AE677A92FCEQ40453290-ADAE5313-C9C9-41CD-B98F-A66C3CD2EBE2Q40555106-F92E169A-6E64-487F-88A0-879A6946441CQ41574249-1B1402F8-42EE-4262-971B-EDB492F9C5C1Q42004462-68BF296E-CA35-4935-B8CD-89DE322C94E1Q57801740-6D870F55-8505-4CD8-A31B-521170C92149
P2860
Characterization of murine TWEAK and its receptor (Fn14) by monoclonal antibodies
description
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2003
@ast
im Juli 2003 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2003/07/11)
@sk
vědecký článek publikovaný v roce 2003
@cs
wetenschappelijk artikel (gepubliceerd op 2003/07/11)
@nl
наукова стаття, опублікована в липні 2003
@uk
مقالة علمية (نشرت في 11-7-2003)
@ar
name
Characterization of murine TWEAK and its receptor (Fn14) by monoclonal antibodies
@ast
Characterization of murine TWEAK and its receptor (Fn14) by monoclonal antibodies
@en
Characterization of murine TWEAK and its receptor (Fn14) by monoclonal antibodies
@nl
type
label
Characterization of murine TWEAK and its receptor (Fn14) by monoclonal antibodies
@ast
Characterization of murine TWEAK and its receptor (Fn14) by monoclonal antibodies
@en
Characterization of murine TWEAK and its receptor (Fn14) by monoclonal antibodies
@nl
prefLabel
Characterization of murine TWEAK and its receptor (Fn14) by monoclonal antibodies
@ast
Characterization of murine TWEAK and its receptor (Fn14) by monoclonal antibodies
@en
Characterization of murine TWEAK and its receptor (Fn14) by monoclonal antibodies
@nl
P2093
P921
P1476
Characterization of murine TWEAK and its receptor (Fn14) by monoclonal antibodies
@en
P2093
Hideo Yagita
Ko Okumura
Masafumi Nakayama
P304
P356
10.1016/S0006-291X(03)01051-9
P407
P577
2003-07-01T00:00:00Z